Retatrutide is structurally derived from the glucagon peptide family and engineered to activate three related class B GPCR receptors involved in metabolic signaling: the GLP 1 receptor, the GIP receptor, and the glucagon receptor
Foundayo (Orforglipron) As the latest addition to GLP-1 weight loss medications, Foundayo was approved in April 2026
If you plan to trade LLY, consider doing so with disciplined risk management, clear levels, and an honest view of volatility
HUBERMAN: And this is very important to understand because unlike a lot of our discussion on this podcast about dopamine or about specific hormones like testosterone or estrogen, when we talk about peptides, especially therapeutic peptides, oftentimes we're talking about a single peptide that does a bunch of different things depending on the cell type, the time of day or night that that peptide is present, and even the different so-called downstream effects of the peptide
Both are easy to add to a routine lab order
PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan with automatic shipments, so your medication is always current and potent
